Dis-Chem Pharmacies Limited (DCP.JO)

ZAc 3675.0

(-0.11%)

EBITDA Summary of Dis-Chem Pharmacies Limited

Dis-Chem Pharmacies Limited's latest annual EBITDA in 2023 was 2.98 Billion ZAR , up 8.95% from previous year.
Dis-Chem Pharmacies Limited's latest quarterly EBITDA in 2024 Q2 was 1.6 Billion ZAR , down 0.0% from previous quarter.
Dis-Chem Pharmacies Limited reported an annual EBITDA of 2.88 Billion ZAR in 2022, up 12.87% from previous year.
Dis-Chem Pharmacies Limited reported an annual EBITDA of 2.49 Billion ZAR in 2021, up 20.94% from previous year.
Dis-Chem Pharmacies Limited reported a quarterly EBITDA of 1.39 Billion ZAR for 2023 Q2, up 99.81% from previous quarter.
Dis-Chem Pharmacies Limited reported a quarterly EBITDA of 721.37 Million ZAR for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Dis-Chem Pharmacies Limited (2023 - 2013)

Historical Annual EBITDA of Dis-Chem Pharmacies Limited (2023 - 2013)

Year	EBITDA	EBITDA Growth
2023	2.98 Billion ZAR	8.95%
2022	2.88 Billion ZAR	12.87%
2021	2.49 Billion ZAR	20.94%
2020	2.06 Billion ZAR	7.79%
2019	1.89 Billion ZAR	30.21%
2018	1.93 Billion ZAR	14.02%
2017	1.37 Billion ZAR	-5.09%
2016	1.3 Billion ZAR	25.3%
2015	1.06 Billion ZAR	29.92%
2014	805.24 Million ZAR	11.33%
2013	722.98 Million ZAR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	1.6 Billion ZAR	0.0%
2023 Q2	1.39 Billion ZAR	99.81%
2023 Q4	721.37 Million ZAR	0.0%
2023 Q1	699.21 Million ZAR	-46.05%
2023 Q3	721.37 Million ZAR	-48.37%
2023 FY	- ZAR	8.95%
2022 Q2	1.45 Billion ZAR	110.74%
2022 FY	- ZAR	12.87%
2022 Q4	1.29 Billion ZAR	89.36%
2022 Q3	684.47 Million ZAR	-52.84%
2022 Q1	688.66 Million ZAR	-44.03%
2021 Q3	436.33 Million ZAR	-70.32%
2021 Q1	581.75 Million ZAR	-43.97%
2021 Q2	1.47 Billion ZAR	152.7%
2021 Q4	1.23 Billion ZAR	181.98%
2021 FY	- ZAR	20.94%
2020 FY	- ZAR	7.79%
2020 Q3	416.22 Million ZAR	-55.36%
2020 Q2	932.45 Million ZAR	149.37%
2020 Q1	373.93 Million ZAR	-60.91%
2020 Q4	1.03 Billion ZAR	149.46%
2019 Q2	867.43 Million ZAR	150.98%
2019 Q3	400.5 Million ZAR	-53.83%
2019 Q1	345.61 Million ZAR	-4.58%
2019 FY	- ZAR	30.21%
2019 Q4	956.57 Million ZAR	138.84%
2018 Q1	434.45 Million ZAR	48.26%
2018 FY	- ZAR	14.02%
2018 Q4	362.22 Million ZAR	0.0%
2018 Q3	362.22 Million ZAR	-16.63%
2018 Q2	434.45 Million ZAR	0.0%
2017 Q2	371.37 Million ZAR	0.0%
2017 Q4	293.03 Million ZAR	0.0%
2017 Q3	293.03 Million ZAR	-21.09%
2017 FY	- ZAR	-5.09%
2017 Q1	371.37 Million ZAR	5.57%
2016 Q1	308.41 Million ZAR	33.07%
2016 FY	- ZAR	25.3%
2016 Q2	308.41 Million ZAR	0.0%
2016 Q3	351.76 Million ZAR	14.05%
2016 Q4	351.76 Million ZAR	0.0%
2015 Q2	282.85 Million ZAR	0.0%
2015 Q4	231.76 Million ZAR	0.0%
2015 Q3	231.76 Million ZAR	-18.06%
2015 Q1	282.85 Million ZAR	74.96%
2015 FY	- ZAR	29.92%
2014 Q3	149.85 Million ZAR	0.0%
2014 Q4	161.67 Million ZAR	7.88%
2014 Q1	149.85 Million ZAR	0.0%
2014 Q2	149.85 Million ZAR	0.0%
2014 FY	- ZAR	11.33%
2013 FY	- ZAR	0.0%
2013 Q4	149.85 Million ZAR	0.0%

Peer EBITDA Comparison of Dis-Chem Pharmacies Limited

Name	EBITDA	EBITDA Difference